Larimar Therapeutics, Inc.
LRMR
8 insider filings · Latest: Feb 27, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Mar 3 12:46 AM | James E FlynnDirector, 10% Owner, Other | Purchase | 5,000,000 | $5.00 | $25.0M | 6,207,982(I) | View → |
| Feb 27, 2026 | Mar 2 9:30 PM | Thomas Edward HamiltonDirector | Purchase | 100,000 | $5.00 | $500.0K | 664,798(D) | View → |
| Feb 27, 2026 | Mar 2 9:30 PM | Frank E ThomasDirector | Purchase | 5,000 | $5.00 | $25.0K | 7,000(D) | View → |
| Feb 27, 2026 | Mar 2 9:30 PM | Jeffrey W ShermanDirector | Purchase | 5,000 | $5.00 | $25.0K | 5,000(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | Jan 27 10:04 PM | Gopi ShankarChief Development Officer | Grant/Award | 153,822 | $3.60 | 153,822(D) | View → |
| Jan 26, 2026 | Jan 27 10:04 PM | Russell ClaytonChief Medical Officer | Grant/Award | 153,822 | $3.60 | 153,822(D) | View → |
| Jan 26, 2026 | Jan 27 10:04 PM | Carole Ben-MaimonDirector, President and CEO | Grant/Award | 600,600 | $3.60 | 600,600(D) | View → |
| Jan 26, 2026 | Jan 27 10:03 PM | Michael CelanoChief Financial Officer | Grant/Award | 225,622 | $3.60 | 225,622(D) | View → |